June 25, 2026
Joint offering creates state-of-the-art workflow uniting Promega's fast and reliable nucleic acid extraction instrumentation with Countable Labs' accurate and easy-to-use Countable PCR technology to deliver accuracy across research PALO ALTO, Calif. & MADISON, Wis. -- Countable Labs, the developer of Countable PCR, a breakthrough single-molecule PCR technology redefining how science measures biology, announced a co-marketing agreement [...]
BioIVT Names Sean Downing, PhD, to Scientific Advisory Board
June 24, 2026
Industry veteran will strengthen BioIVT's scientific strategy by advancing the quality, characterization, and applicability of biospecimens to meet emerging research needs WOODBURY, NY – BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced it has appointed Sean Downing, PhD, to its Scientific Advisory Board to continue advancing the [...]
June 24, 2026
IMU's AI platform unlocks unprecedented immune insights for cancer and other diseases, measuring 100M+ data points from a single blood sample, analyzed in real time. Waters Biosciences' technologies, including BD FACSDiscover™ and BD Rhapsody™ Instruments, will be used with IMU's AI analytics in research to deliver deeper, population-level disease insights. Partnership supports IMU's expansion of [...]
Tecan accelerates Data-Driven Lab journey with Agentic AI developments powered by NVIDIA
June 24, 2026
Männedorf, Switzerland -- Tecan (SIX Swiss Exchange: TECN), a global provider of laboratory automation and solutions, today announced the integration of Agentic AI capabilities into its lab analytics platform Introspect, leveraging NVIDIA BioNeMo Agent Toolkit. The NVIDIA BioNeMo Agent Toolkit enables AI agents to access scientific AI capabilities directly within the Introspect platform, helping laboratories to [...]
Applied Biomics Launches New Antigen Affinity Purified HCP Antibody with 95% Coverage
June 24, 2026
HAYWARD, Calif. -- Applied Biomics, Inc., a leading provider of Host Cell Protein (HCP) products and HCP services, today announced the new Antigen Affinity Purified HCP Antibodies. The new product line expands the company's portfolio of high-performance HCP antibody solutions for use in biopharmaceutical process development and quality control. Unlike conventional antigen affinity-purified antibodies, which often recognize only a [...]
June 24, 2026
ANKENY, Iowa — Proliant Health & Biologicals, a global leader in purified proteins, today announced the commercial launch of AlbufreeDX, a recombinant human albumin (rHA) designed to meet the growing demand for high-performance, animal-free ingredients across diagnostic and life science applications. For more than two decades, Proliant has been a trusted manufacturer of albumin and other [...]
LabCycle receives £180k funding to tackle laboratory plastic waste
June 23, 2026
Bath-based startup, LabCycle, has received £180,000 in funding from the British Design Fund (BDF) to support the development of its ‘world’s first’ AutoDecon system, designed to safely recycle contaminated laboratory plastics into high‑grade resources without high heat or pressure. The investment is part of a broader funding round, alongside a £250,000 Innovate UK Investment Partnership grant [...]
Daniel M. Skovronsky, MD, PhD, appointed to Illumina’s Board of Directors
June 23, 2026
Eli Lilly and Company's Chief Scientific and Product Officer brings pharmaceutical R&D and scientific leadership perspective to Illumina's Board SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) today announced the appointment of Daniel M. Skovronsky, MD, PhD, to its Board of Directors, effective June 16, 2026. Dr. Skovronsky brings extensive experience in drug discovery, clinical development and [...]
VectorBuilder Partners with MaxCyte® to Advance Clinical-Grade Cell Engineering
June 23, 2026
The next-generation platform integrates VectorBuilder’s regulatory-compliant gene delivery technology with MaxCyte’s clinically validated electroporation platform to enable robust, scalable, and reliable clinical-grade cell engineering. Chicago, IL & Rockville, MD – VectorBuilder, a global leader in gene delivery technologies and CDMO services, and MaxCyte, a leading, cell-engineering company providing enabling platform technologies to advance the discovery, development, [...]
NVIDIA Announces BioNeMo Agent Toolkit — Tools for Agents to Accelerate Scientific Discovery
June 23, 2026
News Summary: Industry and research leaders including Dassault Systèmes, Databricks, Lilly, Schrödinger, Snowflake, the UW Medicine Institute for Protein Design and dozens others are adopting, and Anthropic and OpenAI are integrating, NVIDIA BioNeMo Agent Toolkit to bring agentic life sciences workflows to researchers and scientists. NVIDIA BioNeMo Agent Toolkit — including NVIDIA Nemotron, NemoClaw, OpenShell [...]

